Dangerous Drugs

Recent Posts in Dangerous Drugs Category

Blog Home
  • Breast Implants Responsible for Rare Cancer

    Posted By Golomb & Honik, P.C. || 10-May-2017

    Recently, a rare and deadly cancer has claimed the lives of 9 women. Sadly, according to the Food and Drug Administration, these deaths may be directly associated with their breast implants. The extremely rare cancer, known as anaplastic large cell lymphoma (ALCL), is not a type of breast cancer. In fact, it is a rare type of non-Hodgkin’s lymphoma that can be found around the breast ...
    Continue Reading
  • Xarelto Cases Near 14,000

    Posted By Golomb & Honik, P.C. || 13-Mar-2017

    The litigation regarding the drug Xarelto has been ongoing for several years, with more and more consumers submitting claims for internal bleeding injuries—13,727 claims at present. When the Xarelto MDL was first established in December 2014, there were only twenty-one lawsuits. Two years ago, all federal Xarelto claims were consolidated into the Eastern District of Louisiana. Did Johnson ...
    Continue Reading
  • Xarelto Lawsuits Nearing 7,000

    Posted By Golomb & Honik, P.C. || 19-Oct-2016

    For those who have doubted the serious nature of adverse health complications associated with the blood-thinning drug Xarelto, consider there are now more than 7,000 lawsuits filed against the manufacturer of Xarelto. Pharmaceutical giant Bayer manufacturers Xarelto, although it is sold by Janssen, a subsidiary of another pharmaceutical giant, Johnson & Johnson. As of the third week in July ...
    Continue Reading
  • Health Authorities Strengthen Invokana Warnings

    Posted By Golomb & Honik, P.C. || 14-Oct-2016

    Invokana manufacturer Janssen, a subsidiary of beleaguered pharmaceutical giant Johnson & Johnson, faces an ever-increasing number of lawsuits for harm suffered from the drug, and must once again strengthen the drug’s warning label. Both the U.S. and Canada have demanded increased warnings for Invokana, a drug approved for the treatment of Type II diabetes. Invokana (generic ...
    Continue Reading
  • FDA Strengthens Kidney Warnings on Invokana Labeling

    Posted By Golomb & Honik, P.C. || 9-Aug-2016

    A Drug Safety Communication warning was issued by the FDA on June 14, 2016 regarding Invokana (canagliflozin), a Type 2 diabetes drug manufactured by Johnson & Johnson. Invokana works to lower levels of blood sugar by boosting the amount of sugar that is removed through the urine. Another similar SGLT-2 drug, Farxiga (dapagliflozin), was also targeted by the FDA, which asked the manufacturer ...
    Continue Reading
  • Benicar Website Omits Sprue-like Enteropathy

    Posted By Golomb & Honik, P.C. || 21-Jun-2016

    While credit is due to Benicar manufacturer, Daiichi Sankyo, for listing the potential side effects of Benicar on the main Benicar landing page—saving the consumer from having to go from one link to another—the company appears to have omitted one of the primary side effects of the drug. While the site lists various side effects with the drug used to regulate blood pressure, such as ...
    Continue Reading
  • Foot and Leg Amputation & Invokana

    Posted By Golomb & Honik, P.C. || 14-Jun-2016

    A new safety alert sent out by the FDA associates the drugs Invokana and Invokamet (canagliflozin) with nearly twice the risk of leg and foot amputations compared with those taking a placebo. These results came from an ongoing clinical trial known as CANVAS (Canagliflozin Cardiovascular Assessment Study). The safety alert followed a four-and-a-half year interim analysis by an independent CANVAS ...
    Continue Reading
  • Understanding the Dangers of Benicar

    Posted By Golomb & Honik, P.C. || 3-Jun-2016

    There is currently an epidemic of high blood pressure in the United States. Almost one out of every three adults across the nation has the disease, however only about half of those have it under control. Among those 65 and older, high blood pressure will affect more women than men, and is a primary or contributing cause of more than 1,000 deaths each day. While there are many medications used to ...
    Continue Reading
  • PPI Drugs and Chronic Kidney Disease

    Posted By Golomb & Honik, P.C. || 2-Jun-2016

    As the potential dangers of proton pump inhibitor drugs—such as Prilosec, Prevacid and Nexium—continue to come to the light, the most recent study has shown an increased risk of chronic kidney disease among those taking PPI drugs for extended periods of time. PPI drugs were never intended to become a daily pill for Americans – in fact, when the drugs were first approved by the ...
    Continue Reading
  • Xarelto Lawsuits Consolidated into MDL 2592

    Posted By Golomb & Honik, P.C. || 1-Jun-2016

    A hearing held on December 4, 2015 resulted in the Judicial Panel concluding a multi-district litigation was in order to more efficiently take care of the more than 2,800 Xarelto cases that have been filed against Bayer AG and Janssen Pharmaceuticals. MDL consolidation results in faster litigation, as discovery issues are facilitated and conflicting rulings by multiple pre-trial drugs are ...
    Continue Reading
  • More Than 600,000 Bottles of ADHD Medication Recalled

    Posted By Golomb & Honik, P.C. || 23-May-2016

    Although Allergan is selling its generic drug business, Actavis, to Teva, the sale is not yet complete, leaving Allergan on the hook for the recall of more than 600,000 bottles of generic Adderall. The drugs apparently failed impurity level tests, and while the recall was initiated in February, the FDA just classified the recall during the first week of May. The recall of four different dose forms ...
    Continue Reading
  • Chronic Diarrhea, Dehydration and More Linked to Benicar

    Posted By Golomb & Honik, P.C. || 10-May-2016

    As the first round of bellwether Benicar lawsuits grows closer to trial, more and more Benicar patients find themselves suffering significantly from chronic diarrhea, dehydration, and sprue-like enteropathy—a gastrointestinal disorder which can have extremely serious consequences, such as repeated hospitalizations, and even death. While Benicar has been shown to be an effective tool for ...
    Continue Reading
  • Benicar Bellwether Trials Expected Later This Year

    Posted By Golomb & Honik, P.C. || 22-Apr-2016

    The number of Benicar lawsuits continues to increase, with more than 1,250 as of April, 2016. Allergan plc (who acquired Forest Laboratories in July 2014), and the manufacturer of Benicar, Daiichi Sankyo, are currently defending the lawsuits which have increased significantly since early 2015, when there were only about 70 cases. Daiichi Sankyo is a Japanese pharmaceutical company, which maintains ...
    Continue Reading
  • Indiana Woman Files Wrongful Death Claim Against AndroGel

    Posted By Golomb & Honik, P.C. || 19-Apr-2016

    A wrongful death claim has been filed by an Indiana woman, on behalf of her deceased husband, against AbbVie Inc. and Abbott Laboratories, the manufacturers of AndroGel. The case was filed in January 2016, in the U.S. District Court for the District of Pennsylvania. The plaintiff is claiming that her husband died after taking AndroGel, a testosterone replacement drug. The plaintiff’s husband ...
    Continue Reading
  • Did Xarelto Manufacturers Withhold Data from Leading Medical Journal?

    Posted By Golomb & Honik, P.C. || 1-Apr-2016

    Did Xarelto manufacturers purposefully withhold vital data from the New England Journal of Medicine? That is a concern many injured patients have after reanalyzed results raised questions about the faulty drug. An article published in the New York Times, has revealed some startling accusations. Did two of the most major pharmaceutical companies mislead editors of a major medical journal, in order ...
    Continue Reading
  • Drugmakers Back Philadelphia Testosterone Case Consolidation

    Posted By Golomb & Honik, P.C. || 22-Mar-2016

    A group of drug manufacturers including Endo Pharmaceuticals Inc. and AbbVie Inc. are supporting a bid to create a new mass tort program in Pennsylvania state court to consolidate a number of cases alleging that certain testosterone-containing drugs caused strokes and heart attacks. In a summary filed in the Philadelphia Court of Common Pleas earlier this month, attorneys for Endo, AbbVie (later ...
    Continue Reading
  • Woman's Family Recovers $72 Million in Lawsuit Against Johnson & Johnson

    Posted By Golomb & Honik, P.C. || 3-Mar-2016

    According to an article published by Bloomberg Business, Johnson & Johnson is being held responsible to pay $72 million to family members of a woman who experienced fatal injuries after using the talcum powder produced by the company. The woman’s family stated the products, baby powder and an additional talc-based product, caused the women to develop ovarian cancer. This was the first ...
    Continue Reading
  • Early Trials Moving Forward in GranuFlo MDL

    Posted By Golomb & Honik, P.C. || 11-Jan-2016

    Coordinated litigation involving the dialysis products, GranuFlo and NaturaLyte, is moving forward in order for thousands of injured plaintiffs to eventually have their day in court. The judge who is currently overseeing the litigation reviewed the preparation of early trials which may provide important insight into how more than 4,300 cases could potentially be settled in the future. The GranuFlo ...
    Continue Reading
  • 1077 Mass Tort Lawsuits against Benicar

    Posted By Golomb & Honik, P.C. || 4-Jan-2016

    By mid-October 2015, more than 1,077 lawsuits regarding Benicar, a blood pressure drug, have been filed. These cases were filed within a 2015 Benicar MDL in New Jersey after professionals found Benicar caused severe gastrointestinal symptoms among consumers. Tribenzor, Azor, Benicar HCT and Benicar are all included in the litigation since all four drugs are manufactured by Daiichi Sankyo. Benicar ...
    Continue Reading
  • Celebrities Continue to Endorse Xarelto Even as Lawsuits Rise

    Posted By Golomb & Honik, P.C. || 29-Dec-2015

    Even as the number of Xarelto lawsuits nears 2000, Janssen Pharmaceutica has launched an aggressive marketing campaign to increase its revenue and sales of the deadly drug. While Xarelto continues to be prescribed without a known antidote to stop fatal bleeding from occurring, celebrities are still endorsing the medication. Four known celebrities have been featured in prominent television ads. ...
    Continue Reading
  • Zofran Lawsuit Claims Cleft Palate

    Posted By Golomb & Honik, P.C. || 14-Dec-2015

    A mother in Arkansas filed suit against GlaxoSmithKline on September 14, 2015, alleging that the drug company’s anti-nausea drug, Zofran, was responsible for her child’s congenital birth defects. The Arkansas mother joins more than sixty other parents who are currently seeking damages in similar Zofran claims. All the current Zofran claims allege GSK concealed evidence of the link to ...
    Continue Reading
  • Invokana® Linked to Dangerous Side Effects

    Posted By Golomb & Honik, P.C. || 8-Dec-2015

    Invokana® is a prescription drug designed to treat patients struggling to manage Type II diabetes. Janssen Pharmaceuticals markets the drug as safe for use and beneficial for the following reasons: It can aid in weight loss One pill works around the clock Most people taking the medication can reach an A1C of less than 7.0 It significantly lowers blood sugar According to the official ...
    Continue Reading
  • Xarelto Bellwether Trials Set with Allegations of Internal Bleeding

    Posted By Golomb & Honik, P.C. || 7-Dec-2015

    Since Xarelto lawsuits were consolidated in December 2014, more than 1,700 lawsuits have been filed nationwide against Janssen Research and Development and Bayer Healthcare Pharmaceuticals. Earlier in September, a monthly status conference was held to determine the bellwether cases. Bellwether trials are the first trials held in an MDL, and they are used as representative case studies to determine ...
    Continue Reading
  • Johnson & Johnson Seeks Centralization of 103 New Jersey Talcum Powder Cases

    Posted By Golomb & Honik, P.C. || 30-Sep-2015

    Attorneys for the pharmaceutical giant, Johnson & Johnson, are asking that the 103 lawsuits claiming the company’s talcum powder products caused ovarian cancer be consolidated into multicounty litigation. The application on behalf of Johnson & Johnson seeks to have the individual lawsuits centralized in Atlantic County before Superior Court Judge Nelson Johnson. J & J asserts ...
    Continue Reading
  • Testosterone Gel Lawsuits on Fast Track Trial

    Posted By Golomb & Honik, P.C. || 5-Sep-2015

    Nearly 2,000 federal testosterone injury lawsuits have been filed after a significant number of men suffered serious harm following the use of a low testosterone drug such as Axiron, Testim and AndroGel. After an MDL was established in the Northern District of Illinois in June 2014 to centralize the cases, more and more men have come forward to join that MDL. This type of consolidation and ...
    Continue Reading
  • 58 results found. Viewing page 1 of 3. Go to page 1 2 3   Next